Search results for "Sclerosis"

showing 10 items of 1583 documents

DJ-1 mutations and parkinsonism-dementia-amyotrophic lateral sclerosis complex.

2005

Mutations in DJ-1 gene have been recently shown to cause autosomal recessive early-onset Parkinson’s disease (EOPD) in a large Dutch family and in a small consanguineous Italian family.1 Subsequent to this initial finding, several additional DJ-1 mutations were identified in subjects with EOPD.2–6 We describe a family from southern Italy with three brothers affected by a complex disorder characterized by early-onset parkinsonism-dementia-amyotrophic lateral sclerosis (EOPD-D-ALS). The analysis of the DJ-1 gene showed a novel homozygous mutation (E163K) in exon 7 and a novel homozygous mutation (g.168_185dup) in the promoter region of this gene in living affected subjects

MalePathologymedicine.medical_specialtyDNA Mutational AnalysisProtein Deglycase DJ-1Glutamic AcidGene mutationParkinsonismmedicine.disease_causeDISEASEPARK7GUAMExonMucoproteinsDegenerative diseaseParkinsonian DisordersmedicineHumansDementiaRNA MessengerAmyotrophic lateral sclerosisGeneFamily HealthOncogene ProteinsGeneticsMutationReverse Transcriptase Polymerase Chain Reactionbusiness.industryParkinsonismAmyotrophic Lateral SclerosisIntracellular Signaling Peptides and ProteinsExonsDEGENERATIONBlotting Northernmedicine.diseaseGENEINCLUSIONSNeurologyMutationAmyotrophic LateralFemaleDementiaNeurology (clinical)TAUbusiness
researchProduct

Sporadic Parkinson disease and amyotrophic lateral sclerosis complex (Brait-Fahn-Schwartz disease).

2012

Clinical evidence for parkinsonism may accompany Amyotrophic Lateral Sclerosis with a frequency ranging from 5% to 17%. The concurrence of Amyotrophic Lateral Sclerosis and Parkinson's disease, outside the known Guam and Kii Peninsula foci, is instead rare, but this raises the possibility of a common pathogenesis. Clinically this complex presents with a levodopa-responsive parkinsonism and Amyotrophic Lateral Sclerosis and has been termed Brait-Fahn-Schwartz disease. Here we describe two patients with this uncommon neurodegenerative complex. Both presented with Parkinson disease and progressed to a full blown Amyotrophic Lateral Sclerosis. We further suggest that the association of Parkinso…

MalePathologymedicine.medical_specialtyExtrapyramidal signsbusiness.industryParkinsonismAmyotrophic Lateral SclerosisParkinson DiseaseDiseaseMiddle Agedmedicine.diseasenervous system diseasesPathogenesisNeurologyKii peninsulaClinical evidencemedicineHumansFemaleNeurology (clinical)Sporadic Parkinson diseaseAmyotrophic lateral sclerosisbusinessAgedJournal of the neurological sciences
researchProduct

Heterogeneity of atherosclerosis in mesenteric arteries and outgrowth remodeling

2009

Abstract Background In patients with acute mesenteric ischemia by occlusive thrombo-embolism, the superior mesenteric artery (SMA) is more affected than the inferior mesenteric artery (IMA). Methods This study investigated postmortem mesenteric arteries from aged subjects (n=21). Four atherosclerotic stages were defined by signs of degeneration and inflammation in sections stained with Elastica-van-Gieson and immunohistology, respectively. Results In females and males, Stages 3 and 4 were found in 62% of the SMA and 24% of the IMA. Lumenal areas based on diameter measurements remained essentially unchanged between Stages 1 and 4. Compared to a Stage 1 reference, remodeling was associated wi…

MalePathologymedicine.medical_specialtyInflammationSeverity of Illness IndexInferior mesenteric arteryPathology and Forensic MedicineIschemiaMesenteric Artery Superiormedicine.arteryAdventitiaMesenteric Vascular OcclusionLeukocytesmedicineHumansSuperior mesenteric arteryProgenitor cellMesenteric arteriesAgedAged 80 and overInflammationStaining and Labelingbusiness.industryMesenteric Artery InferiorGeneral MedicineAnatomyMiddle AgedAtherosclerosisSMA*Immunohistochemistrymedicine.anatomical_structureVasa vasorumFemaleAutopsyInflammation Mediatorsmedicine.symptomCardiology and Cardiovascular MedicinebusinessCardiovascular Pathology
researchProduct

Investigation of Sudan IV staining areas in aortas of infants and children: Possible prelesional stages of atherogenesis

2009

Although atherosclerosis in infants and children is generally acknowledged, the temporal and spatial sequence of LDL insudation, modification and intimal monocyte accumulation has not been systematically studied. We have investigated herein very early stages of lesion formation in human aortas of individuals up to the age of 15 years. Aortic specimens from 61 cases (37 male, 24 female) were examined. 34 cases were1 year old, 16 cases were between 1 and 5 years old, and 11 cases were between 6 and 15 years old. Areas preselected under a dissection microscope after Sudan IV staining were investigated in depth by immunohistochemical staining for apolipoprotein B, monocytes/macrophages, smooth …

MalePathologymedicine.medical_specialtyLipoprotein modificationAdolescentAorta ThoracicMonocytesmedicine.arterymedicineHumansMacrophageChildAortaApolipoproteins BAortabiologyVascular diseaseMacrophagesC-reactive proteinInfant NewbornInfantAtherosclerosismedicine.diseaseC-Reactive Proteinmedicine.anatomical_structureChild PreschoolImmunologybiology.proteinFemaleTunica IntimaCardiology and Cardiovascular MedicineAzo CompoundsBlood vesselArteryLipoproteinAtherosclerosis
researchProduct

Activation of the Proapoptotic Unfolded Protein Response in Plaques of the Human Carotid Artery

2014

Objective To analyze expression of keystone markers of apoptosis and the proapoptotic signaling pathway “unfolded protein response” (UPR) in rupture-prone plaques of the human carotid artery. Methods Plaque specimens were obtained during endarterectomy for high-grade carotid stenosis, and were formalin-fixed. Ten specimens were identified that exhibited criteria of advanced rupture-prone atherosclerotic plaques, and histological and immunohistological analysis of markers of apoptosis (cleaved Caspase-3, TUNEL) and UPR (KDEL, ATF3, CHOP, CHAC-1) was performed. In addition, co-localization of apoptosis and UPR-activation was assessed by double-immunohistochemistry. Results The mean size of th…

MalePathologymedicine.medical_specialtyReceptors PeptideArteriosclerosisKDELmedicine.medical_treatmentApoptosisCHOPImmunoenzyme TechniquesRisk FactorsIn Situ Nick-End LabelingMedicineHumansCarotid StenosisEndarterectomyAgedAtherosclerotic plaqueAged 80 and overMedicine(all)Endarterectomy CarotidTUNEL assayActivating Transcription Factor 3business.industryCaspase 3MacrophagesFibrous capMiddle AgedImmunohistochemistrymedicine.anatomical_structureCarotid ArteriesApoptosisUnfolded protein responseUnfolded Protein ResponseImmunohistochemistrySurgeryFemalebusinessCardiology and Cardiovascular MedicineBiomarkersTranscription Factor CHOPSignal TransductionEuropean Journal of Vascular and Endovascular Surgery
researchProduct

Expression of vesicle-associated membrane-protein-associated protein B cleavage products in peripheral blood leukocytes and cerebrospinal fluid of pa…

2013

Background and purpose Vesicle-associated membrane-protein-associated protein B (VAPB) is an endoplasmic reticulum (ER) resident protein participating in ER function, vesicle trafficking, calcium homeostasis and lipid transport. Its N-terminal domain, named MSP, is cleaved and secreted, serving as an extracellular ligand. VAPB mutations are linked to autosomal-dominant motor neuron diseases, including amyotrophic lateral sclerosis (ALS) type 8. An altered VAPB function is also suspected in sporadic ALS (SALS). Methods The expression pattern of VAPB cleavage and secreted products in the peripheral blood leukocytes (PBL) and cerebrospinal fluid (CSF) of SALS patients and neurological controls…

MalePathologymedicine.medical_specialtyamyotrophic lateral sclerosisnematode major sperm proteinproteolysisVesicular Transport ProteinsStatistics Nonparametriccerebrospinal fluidCerebrospinal fluidparasitic diseasesLeukocytesmedicineHumansperipheral blood leukocytesSecretionAmyotrophic lateral sclerosisAgedbiologybusiness.industryEndoplasmic reticulumvesicle-associated membrane-protein-associated protein AMiddle AgedVAPBmedicine.diseaseMolecular biologyvesicle-associated membrane-protein-associated protein Bamyotrophic lateral sclerosis cerebrospinal fluid nematode major sperm protein peripheral blood leukocytes proteolysis vesicleassociated membraneprotein- associated protein A vesicleassociated membraneprotein- associated protein BMolecular WeightBlotSettore BIO/12 - Biochimica Clinica E Biologia Molecolare ClinicaVesicle-associated membrane proteinNeurologyMutationbiology.proteinSettore MED/26 - NeurologiaFemaleNeurology (clinical)Antibodybusiness
researchProduct

Decreased Paraoxonase-2 Expression in Human Carotids During the Progression of Atherosclerosis

2008

Objective— Many gene products involved in oxidation and inflammation are implicated in the pathogenesis of atherosclerosis. We investigated paraoxonase 2 (PON2), 5-lipoxygenase (5-LO), and 5-LO activating protein (FLAP) expression and malondialdehyde (MDA) levels in carotid lesions to assess their involvement in plaque formation. Methods and Results— We measured gene expression and MDA levels in atherosclerotic plaques from 59 patients undergoing carotid endarterectomy, and in plaque-adjacent tissue from 41/59 patients. Twenty-three fetal carotids and 6 mammary arteries were also investigated. Real-time polymerase chain reaction and immunohistochemistry revealed decreased PON2 expression i…

MalePathologymedicine.medical_specialtycarotid plaquemedicine.medical_treatment5-Lipoxygenase-Activating ProteinsInflammationCarotid endarterectomySettore MED/22 - Chirurgia VascolareRisk AssessmentSensitivity and SpecificitySeverity of Illness Indexparaoxonase 2 (PON2PathogenesisCohort StudiesTissue Culture TechniquesatherosclerosiPredictive Value of TestsGene expressionmedicineHumansCarotid StenosisMammary ArteriesAgedoxidative streEndarterectomy CarotidArachidonate 5-Lipoxygenasebusiness.industryVascular diseaseAryldialkylphosphataseMembrane ProteinsMiddle Agedmedicine.diseaseAtherosclerosismedicine.anatomical_structureCarotid ArteriesGene Expression RegulationCirculatory systemDisease ProgressionImmunohistochemistryFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessCarrier Proteinsfetal carotid and mammary arteryBiomarkersBlood vessel
researchProduct

Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results…

2009

Background Cognitive impairment is a common symptom of multiple sclerosis (MS), but the association between cognitive impairment and magnetic resonance imaging (MRI) disease measures in patients with relapsing–remitting (RR) MS is unclear. Objectives To study the prevalence of cognitive impairment and its relation with MRI disease measures in mildly disabled patients with RRMS. Methods Patients aged 18–50 years with RRMS (McDonald criteria) and an Expanded Disability Status Scale (EDSS) score ≤4.0, who were enrolled in the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study, underwent baseline standardized MRI complete neurological examination and neuropsychological testing. Results…

MalePediatricsIntelligenceRelapsing-RemittingNeuropsychological TestsSeverity of Illness IndexDisability EvaluationCognitionRisk FactorsOdds RatioPrevalenceNeuropsychological assessmentProspective StudiesNeurologic Examinationmedicine.diagnostic_testCognitive impairmet. Cognitive function. Multiple Sclerosis. Neuropsychological assessment.Cognitive disorderNeuropsychologyAge FactorsMiddle AgedMagnetic Resonance ImagingCognitive testTreatment OutcomeNeurologyItalyFemaleSettore MED/26 - NeurologiaPsychologyAdultmedicine.medical_specialtyMultiple SclerosisAdolescentNeurological examinationRisk AssessmentYoung AdultMultiple Sclerosis Relapsing-RemittingPredictive Value of TestsMagnetic Resonance Imaging; Young Adult; Age Factors; Odds Ratio; Immunologic Factors; Humans; Multiple Sclerosis Relapsing-Remitting; Cognition; Italy; Risk Assessment; Adult; Treatment Outcome; Adolescent; Neuropsychological Tests; Male; Severity of Illness Index; Neurologic Examination; Interferon-beta; Predictive Value of Tests; Cognition Disorders; Cross-Sectional Studies; Intelligence; Prospective Studies; Risk Factors; Disability Evaluation; Middle Aged; Female; PrevalencemedicineHumansImmunologic FactorsExpanded Disability Status ScaleMultiple sclerosisMcDonald criteriaInterferon-betamedicine.diseaseCross-Sectional StudiesPhysical therapyNeurology (clinical)Cognition Disorders
researchProduct

A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy.

2013

Despite the existence of therapeutic guidelines, management of multiple sclerosis relapse remains heterogeneous. Optimisation of relapse outcome demands an improved understanding of the neurologist's therapeutic attitude towards relapse management, which is the aim of this study. Neurologists from 13 multiple sclerosis centres completed a questionnaire every time they assessed multiple sclerosis relapses. The questionnaire requested a guided description of the relapse's clinical characteristics and an indication of the prescribed therapy, supported with up to 3 out of 20 suggested reasons. Over 3 months, 368 questionnaires were collected. Median percentage (%) of 21 relapses resulting in a …

MalePediatricsNeurologyCross-sectional studymulti center studyAdrenal Cortex HormoneAdrenal Cortex HormonesRecurrenceSurveys and QuestionnairesMultiple SclerosiCorticosteroidSurveys and QuestionnaireRelapseSurveyNeuroradiologyGeneral MedicineMiddle AgedManagementPsychiatry and Mental healthMethylprednisoloneItalyNeurologyPsychiatry and Mental Healthmultiple sclerosiSettore MED/26 - NeurologiaFemaleNeurosurgerymedicine.drugHumanAdultmedicine.medical_specialtyMultiple SclerosisDermatologyMethylprednisolonemedicineHumansMedical prescriptionCross-Sectional Studietherapybusiness.industryMultiple sclerosismedicine.diseaseManagement of multiple sclerosisCross-Sectional StudiesHealth Care SurveyHealth Care SurveysPhysical therapyNeurology (clinical)business2708
researchProduct

Analysis of the diagnostic pathway and delay in patients with amyotrophic lateral sclerosis in the Valencian Community

2021

Introduction: Amyotrophic lateral sclerosis (ALS) is an insidious, clinically heterogeneous neurodegenerative disease associated with a diagnostic delay of approximately 12 months. No study conducted to date has analysed the diagnostic pathway in Spain. Methods: We gathered data on variables related to the diagnostic pathway and delay for patients diagnosed with ALS between October 2013 and July 2017. Results: The study included 143 patients with ALS (57% men; 68% spinal onset). Patients were diagnosed in public centres in 86% of cases and in private centres in 14%. The mean diagnostic delay was 13.1 months (median 11.7). Patients were examined by neurologists a mean time of 7.9 months afte…

MalePediatricsmedicine.medical_specialtyDelayed DiagnosisDiseaseValencian communityTrayecto diagnósticomedicineHumansIn patientSymptom onsetNeurologistsAmyotrophic lateral sclerosisRC346-429Referral and Consultationbusiness.industryAmyotrophic lateral sclerosis Diagnostic delay Diagnostic pathway Electrophysiological study Esclerosis lateral amiotrófica Estudio electrofisiológico Retraso diagnóstico Trayecto diagnósticoAmyotrophic Lateral SclerosisNeurodegenerative Diseasesmedicine.diseaseRetraso diagnósticoEstudio electrofisiológicoPrivate healthcareFemaleEsclerosis lateral amiotróficaNeurology. Diseases of the nervous systembusinessHealthcare systemEarly referralNeurología (English Edition)
researchProduct